The publication date of the review is April 2019, (first published online in January), with AVITA supplying 11 references (8 of which were from conferences).
The references are below, with several from last year. Looks comprehensive to me, and disingenuous to suggest or imply its not current.
Also the "economic model" is of critical concern I would have thought. If its not cost effective its unlikely to be widely adopted
.Campbell B, Campbell M. NICE medical technologies guidance: a novel and rigorous methodology to address a new health technology assessment challenge. Appl Health Econ Health Policy. 2012;10:295–7.CrossRefPubMedCentralGoogle Scholar
2.NICE. The ReCell spray-on skin system for treating skin loss, scarring and depigmentation after burn injury (MTG21). 2014. https://www.nice.org.uk/guidance/mtg21. Accessed 15 Nov 2018.
3.Atiyeh BS, Costagliola M, Hayek SN. Burn prevention mechanisms and outcomes: pitfalls, failures and successes. Burns. 2009;35:181–93.CrossRefGoogle Scholar
4.Deitch EA, Wheelahan TM, Rose MP, Clothier J, Cotter J. Hypertrophic burn scars: analysis of variables. J Trauma Acute Care Surg. 1983;23:895–8.CrossRefGoogle Scholar
5.Cubison TC, Pape SA, Parkhouse N. Evidence for the link between healing time and the development of hypertrophic scars (HTS) in paediatric burns due to scald injury. Burns. 2006;32:992–9.CrossRefGoogle Scholar
6.NICE. moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment (MTG2). 2011. https://www.nice.org.uk/guidance/mtg2. Accessed 15 Nov 2018.
8.NBCG (UK National Burn Care Group). International Burn Injury Database: UK burn injury data 1986–2007 inclusive. 2008.Google Scholar
9.Sen S, Ives M, Philp B, Dziewulski P, Herndon D, Wood F. Use of split thickness dermal grafts in combination with sprayed keratinocytes in burns. In: International Society for Burns Injuries Meeting, Edinburgh; Sept 2012.Google Scholar
10.Gravante G, Fede MC, Araco A, Grimaldi M, Angelis B, Arpino A, et al. A randomized trial comparing ReCell system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns. Burns. 2007;33:966–72.CrossRefGoogle Scholar
11.Wood F, Martin L, Lewis D, Rawlins J, McWilliams T, Burrows S. A prospective randomised clinical pilot study to compare the effectiveness of Biobrane synthetic wound dressing, with or without autologous cell suspension, to the local standard treatment regimen in paediatric scald injuries. Burns. 2012;38:830–9.CrossRefGoogle Scholar
12.Park JH, Heggie KM, Edgar DW, Bulsara MK, Wood FM. Does the type of skin replacement surgery influence the rate of infection in acute burn injured patients? Burns. 2013;39:1386–90.CrossRefGoogle Scholar
13.Dunne J, Rawlins J. Early paediatric scald surgery: developing a (cost effective) dermal preserving surgical protocol for all childhood scalds. International Society for Burns Injuries Meeting, Edinburgh; Sept 2012.Google Scholar
14.Rawlins JM. ReCell versus split-thickness skin grafts in the management of deep dermal paediatric scalds. Chinese Burns Association Meeting; 2013 (private communication).Google Scholar
15.Rawlins J, Signy J, Rea S, Wood F. Dermabrasion, ReCell and Biobrane versus split thickness skin grafting for deep flame burns: a comparative pilot study. In: 14th Annual Congress of the European Burns Association, The Hague; Sept 2011.Google Scholar
16.Echlin K, Way B, Jones I. Autologous non-cultured epidermal cell suspension to improve healing in deeper partial thickness facial burns. In: International Society for Burns Injuries Meeting, Edinburgh; Sept 2012.Google Scholar
17.Echlin K, Way B, Jones I. Autologous non-cultured epidermal cell suspension to accelerate healing of split thickness donor sites. In: International Society for Burns Injuries Meeting, Edinburgh; Sept 2012.Google Scholar
18.Palombo M, Bruno A, Santi G, Anniboletti T, Moroni S, Palombo P. Our experience with ReCell: a panel of cases. In: International Society for Burns Injuries Meeting, Edinburgh; Sept 2012.Google Scholar
19.Dunne J, Rawlins J. A comparison of ReCell and split thickness skin grafts in management of paediatric burns. In: International Society for Burn Injuries Meeting, Edinburgh; Sept 2012.Google Scholar
20.Dunne J, Rawlins J. How we do it: early dermal salvage with Biobrane and ReCell in the management of deep dermal burn wounds. In: 15th Congress of the European Burns Association, Vienna; Aug 2013.Google Scholar
21.Hiller M, Limbourg A, Branski L, Vogt P, Jokuszies A. Improving aesthetic outcome: therapy for facial burns with ReCell. In: 15th congress of the European Burns Association, Vienna; Aug 2013.Google Scholar
22.Rennekampff H, Herold C, Vogt M. Keratinocyte suspension for the treatment of facial burns. Burns. 2011;37:S17.CrossRefGoogle Scholar
23.Rawlins J. A prospective randomised clinical trial to investigate and evaluate patient outcomes of Biobrane biosynthetic wound dressings with and without ReCell autologous cell suspension in paediatric scald injuries. In: International Society for Burn Injuries Meeting, Instanbul; June 2010.Google Scholar
24.Rawlins JM, Signy J, Rea S, Wood FM. Biobrane with ReCell for the treatment of deep dermal burns to the legs: a comparative pilot study. J Burn Care Res. 2011;32:S174.Google Scholar
25.Rawlins J. Treatment of deep dermal burns to the legs: a comparative pilot study. In: 44th Meeting of the British Burns Association, Salisbury; Mar 2011.Google Scholar
26.Rawlins J. Early surgery for ALL paediatric scalds: developing a dermal preserving protocol for the benefit of patients and healthcare providers. J Burn Care Res. 2012;33(Suppl. 2):S144.Google Scholar
27.Sood S, Roggy D, Zieger M. Preliminary results with the use of spray keratinocytes in the treatment of partial thickness burns. Burns. 2009;35:S20.CrossRefGoogle Scholar
(20min delay)